Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DiaMedica Therapeutics Inc.DMAC · Entity 5813 | SVP, Clinical Operations | September 15, 2021 | September 15, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DiaMedica Therapeutics Inc.
Report date September 15, 2021 · Filed September 15, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Voting Common Shares, no par value per shareSEC Table I · non-derivative | Direct | 43,582 |
Reported balance
After 2021-09-15 transaction · row 1
1 source rowRow 1 · 2021-09-15 · Purchase · Acquired 15,000 · Balance 43,582 |
| Voting Common Shares, no par value per shareSEC Table I · non-derivative | IndirectBy Spouse | 399 |
Reported balance
Holding disclosure · report date 2021-09-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 399 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2021 Filed Sep 15, 2021 20:37 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseVoting Common Shares, no par value per share | 15,000 | $3.80 | $56,959.50 |
DisclosureSEC source: 0001235802-21-000119 · primary_doc.xml · nonDerivative · entry 1 ALCORN HARRY W JR · CIK 0001186761 · SVP, Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,582 Read SEC document |
| August 16, 2021 Filed Aug 16, 2021 20:27 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseVoting Common Shares, no par value per share | 399 | $3.07 | $1,224.93 |
DisclosureSEC source: 0001235802-21-000099 · primary_doc.xml · nonDerivative · entry 3 ALCORN HARRY W JR · CIK 0001186761 · Senior VP, Clinical Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 399 Read SEC document |
| August 16, 2021 Filed Aug 16, 2021 20:27 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseVoting Common Shares, no par value per share | 322 | $3.06 | $984.93 |
DisclosureSEC source: 0001235802-21-000099 · primary_doc.xml · nonDerivative · entry 2 ALCORN HARRY W JR · CIK 0001186761 · Senior VP, Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,582 Read SEC document |
| August 16, 2021 Filed Aug 16, 2021 20:27 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseVoting Common Shares, no par value per share | 20,000 | $3.09 | $61,844.00 |
DisclosureSEC source: 0001235802-21-000099 · primary_doc.xml · nonDerivative · entry 1 ALCORN HARRY W JR · CIK 0001186761 · Senior VP, Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,260 Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 01:14 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001235802-21-000093 · primary_doc.xml · derivative · entry 2 ALCORN HARRY W JR · CIK 0001186761 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Shares · 60,000 shares Expires 2031-07-27 F1 · derivative.exercise_date: Vests in sixteen nearly equal quarterly installments over four years. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 21:10 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001235802-20-000052 · primary_doc.xml · derivative · entry 2 ALCORN HARRY W JR · CIK 0001186761 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Shares · 35,000 shares Expires 2030-05-31 F1 · derivative.exercise_date: Vests in twelve nearly equal quarterly installments commencing on September 1, 2020. Read SEC document |
| August 16, 2019 Filed Aug 16, 2019 20:35 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseVoting Common Shares, no par value per share | 7,260 | $2.67 | $19,365.32 |
DisclosureSEC source: 0001235802-19-000106 · primary_doc.xml · nonDerivative · entry 1 ALCORN HARRY W JR · CIK 0001186761 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,260 Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:12 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001235802-19-000060 · primary_doc.xml · derivative · entry 2 ALCORN HARRY W JR · CIK 0001186761 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Shares · 125,000 shares Expires 2029-06-23 F1 · derivative.exercise_date: Vests in eight equal quarterly installments over two years. Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 20:15 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | GiftVoting Common Shares, no par value per share | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-19-000030 · primary_doc.xml · nonDerivative · entry 2 ALCORN HARRY W JR · CIK 0001186761 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 20:15 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseVoting Common Shares, no par value per share | 150 | $4.46 | $668.39 |
DisclosureSEC source: 0001235802-19-000030 · primary_doc.xml · nonDerivative · entry 1 ALCORN HARRY W JR · CIK 0001186761 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150 Read SEC document |
| December 11, 2018 Filed Dec 11, 2018 21:08 UTC | DiaMedica Therapeutics Inc. DMAC · Entity 5813 | PurchaseVoting Common Shares, no par value per share | 1,000 | $4.00 | $4,000.00 |
DisclosureSEC source: 0001235802-18-000178 · primary_doc.xml · nonDerivative · entry 1 ALCORN HARRY W JR · CIK 0001186761 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.